ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Ranolazine Mechanism of Action, Manufacturing Process, and API manufacturers in China
May 17, 2021Ranolazine is a piperazine derivative belonging to the anti-anginal class of drugs. It is mainly used for the management of stable angina pectoris. Chronic angina leads to ongoing chest pain or pressure, which is felt when the heart does not receive enoug -
Lupin launches chronic angina treatment drug in the US
March 01, 2019The newly-launched product, in strengths of 500 mg and 1,000 mg, is a generic version of Gilead Sciences’ Ranexa ER tablets
Pharma Sources Insight January 2025
